9 results match your criteria: "CAMB UMR7199 CNRS-Université de Strasbourg[Affiliation]"
Macromol Biosci
June 2024
3Bio Team, CAMB UMR7199, Faculté de Pharmacie, CNRS-Université de Strasbourg, 74 route du Rhin, Illkirch Cedex, F-67401, France.
The physiological problem of chronic inflammation and its associated pathologies attract ongoing attention with regard to methods for their control. Current systemic pharmacological treatments present problematic side effects. Thus, the possibility of new anti-inflammatory compounds with differing mechanisms of action or biophysical properties is enticing.
View Article and Find Full Text PDFJ Funct Biomater
December 2022
3Bio Team, Faculté de Pharmacie, CAMB UMR7199 CNRS-University of Strasbourg, 74 route du Rhin, F-67401 Illkirch, France.
Cationic polymers such as polyethylenimine (PEI) have found a pervasive place in laboratories across the world as gene delivery agents. However, their applications are not limited to this role, having found a place as delivery agents for drugs, in complexes known as polymer-drug conjugates (PDCs). Yet a potentially underexplored domain of research is in their inherent potential as anti-cancer therapeutic agents, which has been indicated by several studies.
View Article and Find Full Text PDFCancers (Basel)
October 2022
3Bio Team, CAMB UMR7199 CNRS, Faculté de Pharmacie, University of Strasbourg, 67401 Ilkirch, France.
The difficulty involved in the treatment of many tumours due to their recurrence and resistance to chemotherapy is tightly linked to the presence of cancer stem cells (CSCs). This CSC sub-population is distinct from the majority of cancer cells of the tumour bulk. Indeed, CSCs have increased mitochondrial mass that has been linked to increased sensitivity to mitochondrial targeting compounds.
View Article and Find Full Text PDFChem Biol Interact
November 2022
3Bio Team, CAMB UMR7199 CNRS-Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, F-67401 Illkirch cedex, France. Electronic address:
Cancer stem cells (CSCs) represent a difficult to treat cellular niche within tumours due to their unique characteristics, which give them a high propensity for resistance to classical anti-cancer treatments and the ability to repopulate the tumour mass. An attribute that may be implicated in the high rates of recurrence of certain tumours. However, other characteristics specific to these cells, such as their high dependence on mitochondria, may be exploited for the development of new therapeutic agents that are effective against the niche.
View Article and Find Full Text PDFRev Mal Respir
March 2020
Chest diseases department, Strasbourg University Hospital, 1, place de l'Hôpital, 67000 Strasbourg, France; Federation of translational medicine EA 3070, University of Strasbourg, BP426, 67091 Strasbourg, France.
Int J Obes (Lond)
November 2019
Laboratoire de Pharmacologie et Toxicologie NeuroCardiovasculaire (LPTNC) - EA7296, Faculté de Médecine, Fédération de Médecine Translationnelle, Université de Strasbourg, Strasbourg, France.
Background/objectives: We previously observed that selective agonists of the sympatho-inhibitory I imidazoline receptors (LNP ligands) have favorable effects on several cardiovascular and metabolic disorders defining the metabolic syndrome, including body weight. The objectives of this study were to explore the effects of LNPs on adiposity and the mechanisms involved, and to evaluate their impact on metabolic homeostasis.
Methods: Young Zucker fa/fa rats were treated with LNP599 (10 mg/kg/day) for 12 weeks.
Nanoscale
January 2018
V-SAT Laboratory, Vectors: Synthesis and Therapeutic Applications, Labex Medalis, CAMB UMR7199 CNRS-Université de Strasbourg, Faculty of Pharmacy, Illkirch, France.
Polydiacetylenic nanofibers (PDA-Nfs) obtained by photopolymerization of surfactant 1 were optimized for intracellular delivery of small interfering RNAs (siRNAs). PDA-Nfs/siRNA complexes efficiently silenced the oncogene Lim-1 in the renal cancer cells 786-O in vitro. Intraperitoneal injection of PDA-Nfs/siLim1 downregulated Lim-1 in subcutaneous tumor xenografts obtained with 786-O cells in nude mice.
View Article and Find Full Text PDFJ Med Chem
April 2015
‡Laboratoire d'Innovation Thérapeutique, MEDALIS Drug Discovery Center, Faculté de Pharmacie, LIT UMR7200 CNRS/Université de Strasbourg, 74 Route du Rhin, 67401 Illkirch, France.
The blood fluke Schistosoma mansoni is the causative agent of the intestinal form of schistosomiasis (or bilharzia). Emergence of Schistosoma mansoni with reduced sensitivity to praziquantel, the drug currently used to treat this neglected disease, has underlined the need for development of new strategies to control schistosomiasis. Our ability to screen drug libraries for antischistosomal compounds has been hampered by the lack of validated S.
View Article and Find Full Text PDFBioorg Med Chem
March 2011
Laboratoire de Chimie Génétique, UMR7199 CAMB, CNRS et Université de Strasbourg, Faculté de Pharmacie, 67401 Illkirch, France.
Solid phase spermine oligomerization via guanidine linkers was achieved using activated thiourea coupling reaction with primary amino group. Disymmetric spermine synthon was efficiently synthesised in eight steps from spermine. MMT group was used as coupling monitor and resulting oligomeric spermines were conjugated to oligonucleotides.
View Article and Find Full Text PDF